Cullinan Therapeutics, Inc.

8-K Shareholder vote results Jun 16, 2026 8-K Regulation FD disclosure; Other events Jun 10, 2026 8-K Regulation FD disclosure; Other events Jun 8, 2026 8-K Regulation FD disclosure; Other events May 18, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release) Mar 10, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 8, 2026 8-K Regulation FD disclosure; Other events Dec 8, 2025 8-K Terminated a material agreement Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Other events Nov 6, 2025 8-K Regulation FD disclosure; Other events Nov 3, 2025 8-K Regulation FD disclosure; Other events Sep 4, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Director or officer change Aug 7, 2025 8-K Shareholder vote results Jun 12, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Regulation FD disclosure; Other events Jan 29, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Regulation FD disclosure; Other events Oct 16, 2024 8-K Regulation FD disclosure; Other events Sep 17, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Shareholder vote results Jun 27, 2024 8-K Regulation FD disclosure; Other events Jun 3, 2024 8-K Regulation FD disclosure; Other events May 23, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release); Director or officer change May 15, 2024 8-K Director or officer change Apr 29, 2024 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure; Other events Apr 16, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K Results of operations (earnings release) Mar 14, 2024 8-K/A Results of operations (earnings release) Jan 8, 2024